Health food

  • DATABASE (331)

  • ARTICLES (378)

    • DATABASE (331)
    • ARTICLES (378)
  • Sort by
    • Relevance
    • Date

As a graduate in Biomedical Engineering from Southeast University as well as Clinical Medicine from Nanjing Medical University, Chai Xueting has always been aware of the issues plaguing the traditional medical imaging system. The exorbitant cost of archiving past records and the lack of a comprehensive medical image sharing system between hospitals for a fully effective diagnosis have long raised concerns in his mind.  But it was while taking his young daughter to the hospital for a health checkup, personally experiencing these issues, that Chai became ever more determined to build a cloud-based medical system – hence his founding of Eimageglobal.  In 2017, Chai won the “Young Tech Giant” Award by Zhejiang Entrepreneur Committee. 

Patrão is a Portuguese co-founder at UpHill whose SaaS helps healthcare professionals keep up-to-speed on the latest clinical treatments and protocols using AI. Despite being heavily involved in the development of the software Simulate, Patrão continues to work in the medical field full-time.He has spent the last decade working at Viseu’s Tondela Hospital Center in the intensive care unit as a physician. He also lectures part-time at his former university Beira Interior, where UpHill was established, and is a researcher for the RISRECP,  the Colombia-based Iberian Network of Researchers in Renal Health and Common Chronic Illnesses.The co-founder also helps produce clinical simulations for producer Hands on Education and holds a doctorate in Medicine from Beira Interior University.

Based in Seattle, Washington, Pivotal Ventures was founded by Melinda Gates in 2015 as a separate, independent organization from the Bill & Melinda Gates Foundation. The VC-arm and incubator aim to foster social innovation in the US, focusing on the social progress of women and families. It has supported diversity & inclusion, healthcare and impact startups by providing early-stage funding to enterprises with philanthropic and scalable goals. In October 2020, Pivotal launched a fund for adolescent mental health in partnership with Panorama Global. In September 2020, it also joined Techstars to create a new accelerator program to find innovative eldercare solutions for seniors and their caregivers.

Founded in 2009, Finnish VC Lifeline Ventures has invested in over 100 early-stage startups, with investments ranging from €100,000 to €2m. Focusing mainly on local tech startups, the VC has 71 tech and non-tech companies in its portfolio.Recent investments in April 2021 include the $100m Series C round of Finnish wellness ring and app Oura Health and the $6.2m seed round of Finnish cleantech Carbo Culture. One of Lifeline’s VC partners, Timo Ahopelto, is an advisor at student-led VC Wave Ventures that also participated in the investment round of Carbo Culture.

Natural Machines is launching the world’s first commercial 3D food printing and laser beam cooking machine for affordable, personalized meals, endorsed by Michelin-starred restaurants.

Felix Cheung graduated in physics from Adelaide’s Flinders University in 1999 and obtained a PhD in physics from the University of Sydney in 2005. He obtained a master’s in food analysis and food safety management from Hong Kong Baptist University in 2015. Cheung met Elton Ho during the master’s program at university and they teamed up to co-develop the advanced sous-vide aseptic packaging (ASAP) technology. In January 2017, they established IXON Food Technology to further develop and commercialize ASAP for the food industry.Cheung previously worked as a website designer and administrator at the Complex Plasma Laboratory, University of Sydney, from 2002–2006. He was also an editor at Macmillan Science Communication for one year before joining the Springer Nature publishing group to work as editor at Nature China from 2007–2014.

Gabriel de Maeztu is CTO and co-founder of IOMED Medical Solutions, which facilitates data extraction from electronic health records (EHR) and where he has worked since 2016. He had the idea for the software in 2014 and worked on it from then, completing two internships during that time: at QMENTA, formerly Mint Labs, a US drug development startup dedicated to brain diseases (where he worked in data science) and at Barcelona bioresearch center IDIBAPS in neuro-imaging research.De Maeztu holds a doctorate in Medicine from the International University of Catalonia, where he first had the idea for IOMED. He also holds a bachelor’s in Mathematics and a postgraduate qualification in Data Processing, Data Science and Big Data. He was also previously a developer at Barcelona tech agency Chroma Branding. 

Ibersol is a Portuguese restaurant sector investor established in 1994. It holds the franchises of several of Spain and Portugal's top-selling fast-food chains including Burger King in both nations, Pans & Company in Spain and KFC in Portugal and Angola.To date, it has invested in one startup, the Portuguese healthy food service EatTasty, with undisclosed investment in the company's seed stage, phase one, that raised €1.1m. It also acquired one food sector entity, the Spanish restaurant group, Eat Out Group, for an undisclosed sum in 2016.

Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.

Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas. 

Based in San Francisco, Slow Ventures was founded in 2011 by an early Facebook employee David Morin, who helped to build the Facebook Platform and Facebook Connect. Slow Ventures is no longer known as the “Facebook Alumni Fund”.Today, the VC is a generalist fund, investing in diverse sectors worldwide, ranging from digital health to enterprise solutions. The firm has backed unicorn startups in the US like Postmates, Nextdoor, AngelList and Evernote. A fourth fundraising round has been launched for two new funds totaling $220m: seed funding of $165m and $55m for a follow-up round. Its last funding round closed at $145m in 2016.

Fang Shihun is a serial entrepreneur who graduated with a BSc Applied Mathematics at Emory University in 2014. He founded Shanghai-based Pingyuan App-Ark Education Consulting and became its president from 2009 to January 2015. He also co-founded Shanghai Sanxin Investment Ltd in February 2015 and founded Puyang Food in July the same year. Shiheng Tech was founded in April 2017. Based in Shanghai, he is now the CEO at Puyang Food and Shiheng Tech.  

Xu Hanhan graduated from the Guanghua School of Management, Peking University, in 2008. She then worked at the VC, China Renaissance Capital Investment, and later became personal assistant to ByteDance CEO and founder Zhang Yiming during the startup's early years. She co-founded Waterdrop in 2016 and is now in charge of Waterdrop Crowdfunding. She also started another of Waterdrop's platforms, Waterdrop Public Wellness, which helps charitable organizations fundraise as well as report on the usage of the funds received. 

Sanchez is a computer and data science expert with a master’s degree in innovation and research in informatics with specialization in advanced computing from the Polytechnic University of Barcelona (UPC). He also holds multiple certifications from the John Hopkins University School of Education. Sanchez is currently CTO and co-founder of HumanITcare, a telemedicine platform for remote patient monitoring using real-world data and AI to treat patients affected by chronic diseases and also to accelerate drug development and clinical trials. Prior to HumanITcare, Sanchez worked as Data Scientist in a joint-project between the Spanish insurance company Catalana Occidente and technology consultancy Raona to develop a sales collaborative platform. He has also worked on projects in software development, mobile apps, server and hardware as well as prototyping for IoT devices in the fields of education, health and wellness.

Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.

Sorry, we couldn’t find any matches for “Health food”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.